Category: Uncategorized

This month’s edition provides a focused review of newly approved and recently launched therapies. Expion Health monitors these developments closely to assess clinical relevance, therapeutic positioning, and potential implications for payers, providers, and patients. IndicationYUVEZZI (carbachol and brimonidine tartrate) is the first and only preservative-free dual-agent ophthalmic drop approved for the treatment of presbyopia in adults. … Rx Insights from February ’26

This month’s edition provides a focused review of newly approved and recently launched therapies. Expion Health monitors these developments closely to assess clinical relevance, therapeutic positioning, and potential implications for payers, providers, and patients. Indication NEREUS (tradipitant) is a substance P/neurokinin-1 (NK-1) receptor antagonist indicated for the prevention of motion-induced vomiting in adults. Dosage and … RX Insights from January ’26